Tudor Investment Corp’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-142,999
Closed -$960K 4054
2025
Q3
$960K Sell
142,999
-196,335
-58% -$1.28M ﹤0.01% 2301
2025
Q2
$2M Sell
339,334
-4,156
-1% -$27.1K ﹤0.01% 1674
2025
Q1
$2.88M Buy
343,490
+125,803
+58% +$1.13M 0.01% 1106
2024
Q4
$1.62M Buy
217,687
+30,586
+16% +$205K 0.01% 1390
2024
Q3
$1.09M Buy
+187,101
New +$1.2M ﹤0.01% 1567
2024
Q2
Sell
-127,669
Closed -$1.67M 2796
2024
Q1
$1.67M Buy
127,669
+75,194
+143% +$1M 0.01% 1107
2023
Q4
$669K Sell
52,475
-90,055
-63% -$910K 0.01% 1633
2023
Q3
$1.87M Buy
+142,530
New +$2.61M 0.02% 965
2023
Q1
Sell
-110,393
Closed -$2.54M 2949
2022
Q4
$2.54M Buy
110,393
+38,357
+53% +$883K 0.05% 505
2022
Q3
$1.59M Buy
72,036
+55,402
+333% +$1.07M 0.03% 629
2022
Q2
$239K Buy
+16,634
New +$280K 0.01% 1714

Other funds holding TMCI

Tudor Investment Corp's TMCI Position: Q4 2025 in Review

Tudor Investment Corp sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 142,999 shares — an estimated $960K sold.

Tudor Investment Corp first reported a position in TMCI in Q2 2022 and held it in 11 quarters. The position peaked at $2.88M in Q1 2025. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Tudor Investment Corp reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 142,999 Treace Medical Concepts shares in Q4 2025, an estimated $960K.
  • Tudor Investment Corp first reported a position in Treace Medical Concepts in Q2 2022 and held it in 11 quarters.
  • Tudor Investment Corp's Treace Medical Concepts position peaked at $2.88M in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.